Additionally, metabolic changes during HD, including altered gluconeogenesis, reduced insulin clearance, glucose loss to the dialysate, and intracellular glucose diffusion, contribute to hypoglycemia but are difficult to monitor in routine clinical practice (Abe and Kalantar-Zadeh, 2015). This evidence concerns the gene INS and Hypoglycemia.